2024-08-01 2025-07-31 false Capium Accounts Production 1.1 15023919 2024-08-01 2025-07-31 15023919 bus:AbridgedAccounts 2024-08-01 2025-07-31 15023919 bus:FRS102 2024-08-01 2025-07-31 15023919 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 15023919 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 15023919 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 15023919 2024-08-01 2025-07-31 15023919 2025-07-31 15023919 bus:RegisteredOffice 2024-08-01 2025-07-31 15023919 core:WithinOneYear 2025-07-31 15023919 core:AfterOneYear 2025-07-31 15023919 1 2024-08-01 2025-07-31 15023919 bus:Director1 2024-08-01 2025-07-31 15023919 bus:Director1 2025-07-31 15023919 bus:Director1 2023-07-24 2024-07-31 15023919 2023-07-24 15023919 bus:LeadAgentIfApplicable 2024-08-01 2025-07-31 15023919 2023-07-24 2024-07-31 15023919 2024-07-31 15023919 core:WithinOneYear 2024-07-31 15023919 core:AfterOneYear 2024-07-31 15023919 bus:EntityAccountantsOrAuditors 2023-07-24 2024-07-31 15023919 core:CostValuation core:Non-currentFinancialInstruments 2025-07-31 15023919 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 15023919 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-07-31 15023919 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 15023919 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 15023919 core:Non-currentFinancialInstruments 2025-07-31 15023919 core:Non-currentFinancialInstruments 2024-07-31 15023919 core:ShareCapital 2025-07-31 15023919 core:ShareCapital 2024-07-31 15023919 core:RetainedEarningsAccumulatedLosses 2025-07-31 15023919 core:RetainedEarningsAccumulatedLosses 2024-07-31 15023919 dpl:Item1 2024-08-01 15023919 dpl:Item1 2025-07-31 15023919 dpl:Item1 2023-07-24 15023919 dpl:Item1 2024-07-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 15023919
THARANGA CLINICAL LTD
Abridged Accounts
Period of accounts Start date: 01 August 2024 End date: 31 July 2025

THARANGA CLINICAL LTD Contents Page For the year ended 31 July 2025
Accountants' report | 1
Statement of financial position | 2
Notes to the financial statements | 3

THARANGA CLINICAL LTD Accountants' Report For the year ended 31 July 2025
In our capacity as professional accountants at ZATRS ACCOUNTING LIMITED, and in accordance with your instructions, we have prepared the unaudited statutory financial statements of THARANGA CLINICAL LTD for the year ended 31 July 2025. These financial statements, comprising the income statement, statement of income and retained earnings, statement of financial position, and related notes, have been compiled from the accounting records and information you have provided to us. As a practice member of the institute of CPAA, I adhere to the ethical guidelines and professional standards expected within the accounting profession. Our role in preparing these financial statements is solely to present the financial information based on the data provided by the management of THARANGA CLINICAL LTD. This report is addressed solely to the Board of Directors of THARANGA CLINICAL LTD, as a body, in accordance with the terms of our engagement. Our work has been limited to preparing these financial statements and stating the matters outlined in this report. We have relied on the agreement made with the Board of Directors of THARANGA CLINICAL LTD, as a body, and this report is in accordance with CPAA rules and regulations. To the fullest extent permitted by law, ZATRS ACCOUNTING LIMITED does not accept or assume responsibility to anyone other than THARANGA CLINICAL LTD and its Board of Directors, as a body, for our work or for this report. It is the responsibility of the management of THARANGA CLINICAL LTD to ensure that the company has maintained adequate accounting records and to prepare statutory financial statements that present a true and fair view of the assets, liabilities, financial position, and loss of THARANGA CLINICAL LTD. You have acknowledged that THARANGA CLINICAL LTD is exempt from the statutory audit requirement for the year. We confirm that we have not been instructed to carry out an audit or a review of the financial statements of THARANGA CLINICAL LTD. Consequently, we have not verified the accuracy or completeness of the accounting records or information you have given to us, and therefore, we do not express any opinion on the statutory financial statements. .................................................... ZATRS ACCOUNTING LIMITED 29 Debnam Grove Sittingbourne Kent ME10 3FN 28 January 2026 1

Registered Number: 15023919 THARANGA CLINICAL LTD Statement of Financial Position As at 31 July 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Current assets |  |  |
Debtors |  | 427 |  | 0
Cash at bank and in hand |  | 3,399 |  | 2,395
|  | 3,826 |  | 2,395
Creditors: amount falling due within one year |  | (17,326) |  | (3,326)
Net current assets |  | (13,500) |  | (931)
Total assets less current liabilities |  | (13,500) |  | (931)
Net assets |  | (13,500) |  | (931)
Capital and reserves |  |  |
Called up share capital |  | 1 |  | 1
Profit and loss account |  | (13,501) |  | (932)
Shareholders' funds |  | (13,500) |  | (931)
For the year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 06 February 2026 and were signed by:
------------------------------- Poorvie Hewa Pathiranage Director
2

THARANGA CLINICAL LTD Notes to the Abridged Financial Statements For the year ended 31 July 2025
General Information THARANGA CLINICAL LTD is a private company, limited by shares, registered in , registration number 15023919, registration address 14 HOPKIN CLOSE, GUILDFORD ENGLAND, GU2 9LS. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Going concern basis The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements. Turnover Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances. Taxation Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities. Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively. Dividends Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
2. | Average number of employees Average number of employees during the year was 2 (2024 : 2).
3